Microtransplantation: a new hope for advanced cancer patients?
NCT ID NCT07356856
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests a procedure called microtransplantation (MST) combined with chemotherapy in 10 adults with advanced or relapsed solid tumors. The goal is to see if MST can help control the disease and improve recovery of blood cells after chemo. The study focuses on safety and how well the treatment works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED AND RELAPSED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Innovvy(Beijing) Biomedical Technology Co., Ltd
Haidian, Beijing Municipality, China
-
Minzu Hospital of Guangxi Zhuang Autonomous Region
Nanning, Guangxi, China
-
The First People's Hospital of Nanning
Nanning, Guangxi, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injection shrink Hard-to-Treat tumors?
- Can a new drug shrink Hard-to-Treat tumors?
- Can a Dual-Action antibody outsmart resistant tumors?
- Can your own immune cells beat advanced cancer?
- Tumor DNA mapping may unlock personalized cancer therapies
- Can a new drug combo shrink Hard-to-Treat tumors?